08.220.2024 - Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further.  In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate Read Article - View Press Release - Visit NVIDIA Corporation